From: Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension
Univariate | Model 1† | Model 2‡ | ||||
---|---|---|---|---|---|---|
Variables | p | Hazard ratio (95% CI) | p | Hazard ratio (95% CI) | p | Hazard ratio (95% CI) |
Age, year | 0.51 | 1.01 (0.98--1.04) | ||||
Women | 0.71 | 0.78 (0.22--2.83) | ||||
CTD-associated | 0.29 | 0.49 (0.16--1.46) | ||||
Mean RA pressure, mm Hg* | 0.05 | 1.19 (1.00--1.43) | ||||
Mean PA pressure, mm Hg* | 0.34 | 0.99 (0.95--1.02) | ||||
Cardiac index, L/min/m2 | 0.70 | 1.14 (0.58--2.24) | ||||
WHO functional class | <0.001 | 4.95 (2.17--11.32) | 0.009 | 3.30 (1.35--8.03) | ||
Doppler RV index | 0.17 | 3.03 (0.61--14.99) | ||||
BNP, lognormal pg/dL | 0.001 | 2.79 (1.55--5.04) | 0.004 | 2.35 (1.31 -- 4.21) | ||
Elevated AST | 0.34 | 0.37 (0.05--2.84) | ||||
Elevated ALT | 0.30 | 0.34 (0.04--2.60) | ||||
Elevated LDH | 0.17 | 2.10 (0.73--6.12) | ||||
Hyperbilirubinemia | <0.001 | 13.31 (3.91--45.30) | 0.02 | 4.81 (1.24--18.73) | ||
Bilirubin, mg/dL | 0.001 | 3.64 (1.73--7.68) | 0.02 | 2.28 (1.15 -- 4.52) |